The new flu numbers have been released by the CDC and 1/3 of all tests are positive for the flu. Additionally, Georgia flu activity is considered to be "very high" at ...

- Based on these results, Incyte plans to file a supplemental Biologics License Application (sBLA) for tafasitamab and lenalidomide in addition to R-CHOP in first-line diffuse large B-cell lymphoma ...

Domestic markets are likely to open flat on Tuesday amid lack of global cues and domestic triggers. With the return of FPIs as buyers, markets are likely to sustain the momentum, said analysts. Global ...

Slop, ragebait, glazing, parasocial, taskmasking, gerrymandering . . . the words of 2025 haven't exactly been swinging from the chandeliers. From low-quality AI drivel to rage-inducing clickbait, fake ...

Daiichi Sankyo and AstraZeneca's Enhertu has been cleared for previously-untreated HER2-positive breast cancer in the US, becoming the first new first-line option in more than a decade. The FDA ...

Domestic markets are likely to open on a flat note on Friday. Analysts expect the market to remain thin and lacklustre amid a lack of triggers. Ponmudi R, CEO of Enrich Money, said US equities closed ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

President Donald Trump’s approval rating has hovered at around 40% for the duration of his term—despite an 11-point drop in views of his handling of immigration, as violent clashes with ICE officers ...

Cardano gains nearly 4% on Monday, extending the rally after a bullish RSI divergence. Derivatives data signals a rise in bullish bets as traders increase their capital exposure in ADA futures.